Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: A retrospective study

被引：0
|
作者：
Li, Rongrong
Zhou, Hui-Jun
Zeng, De-Yu
Jiang, Shao-Feng
Liu, Wu
Liu, Zhen-yang
机构：
[1] Cent South Univ, Dept Med Oncol Gastroenterol & Urol, Hunan Canc Hosp, Affiliated Canc Hosp,Xiangya Sch Med, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Dept Gastroenterol & Urol,Hunan Canc Hosp, Changsha, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15562
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer-single institutional experience
    Okunaka, Mashiro
    Kawazoe, Akihito
    Nakamura, Hitomi
    Kotani, Daisuke
    Mishima, Saori
    Kuboki, Yasutoshi
    Nakamura, Yoshiaki
    Shitara, Kohei
    GASTRIC CANCER, 2023, 26 (06) : 1030 - 1039
  • [22] Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer
    Celeste B. Burness
    Sean T. Duggan
    Drugs, 2016, 76 : 1393 - 1402
  • [23] Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer
    Zaniboni, Alberto
    Barone, Carlo Antonio
    Banzi, Maria Chiara
    Bergamo, Francesca
    Blasi, Livio
    Bordonaro, Roberto
    Di Bartolomeo, Maria
    Di Costanzo, Francesco
    Frassineti, Giovanni Luca
    Garufi, Carlo
    Giuliani, Francesco
    Latiano, Tiziana Pia
    Martinelli, Erika
    Personeni, Nicola
    Racca, Patrizia
    Tamburini, Emiliano
    Tonini, Giuseppe
    Besse, Marie Georges
    Spione, Mario
    Falcone, Alfredo
    FUTURE ONCOLOGY, 2021, 17 (18) : 2315 - 2324
  • [24] Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer
    Burness, Celeste B.
    Duggan, Sean T.
    DRUGS, 2016, 76 (14) : 1393 - 1402
  • [25] Metastatic Colorectal Cancer Management with trifluridine/tipiracil
    White, Teresa
    Larson, Heidi
    Minnella, Alexandra
    Hochster, Howard S.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (02) : E30 - E37
  • [26] The safety and efficacy of trifluridine-tipiracil for metastatic colorectal cancer: A pharmacy perspective
    Chan, Betty M.
    Hochster, Howard S.
    Lenz, Heinz-Josef
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (06) : 339 - 348
  • [27] Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
    Martinez-Lago, Nieves
    Calleja Chucla, Teresa
    Alonso De Castro, Beatriz
    Varela Ponte, Rafael
    Reboredo Rendo, Cristina
    Gomez-Randulfe Rodriguez, Martin Igor
    Silva Diaz, Sofia
    Grana Suarez, Begona
    de la Camara Gomez, Juan
    Busto Fernandez, Fernando
    Mateos Salvador, Maria
    Reboredo Lopez, Margarita
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [28] Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer
    Gianluca Arrichiello
    Alessandra Perrone
    Stefania Napolitano
    Giulia Martini
    Vincenzo De Falco
    Pasquale Incoronato
    Maria Maddalena Laterza
    Gaetano Facchini
    Vincenzo Famiglietti
    Valeria Nacca
    Fernando Paragliola
    Rossella Napolitano
    Gabriella Suarato
    Antonella Nicastro
    Erika Martinelli
    Davide Ciardiello
    Fortunato Ciardiello
    Teresa Troiani
    Targeted Oncology, 2022, 17 : 635 - 642
  • [29] Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer
    Arrichiello, Gianluca
    Perrone, Alessandra
    Napolitano, Stefania
    Martini, Giulia
    De Falco, Vincenzo
    Incoronato, Pasquale
    Laterza, Maria Maddalena
    Facchini, Gaetano
    Famiglietti, Vincenzo
    Nacca, Valeria
    Paragliola, Fernando
    Napolitano, Rossella
    Suarato, Gabriella
    Nicastro, Antonella
    Martinelli, Erika
    Ciardiello, Davide
    Ciardiello, Fortunato
    Troiani, Teresa
    TARGETED ONCOLOGY, 2022, 17 (06) : 635 - 642
  • [30] Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
    Nieves Martínez-Lago
    Teresa Calleja Chucla
    Beatriz Alonso De Castro
    Rafael Varela Ponte
    Cristina Reboredo Rendo
    Martin Igor Gomez-Randulfe Rodriguez
    Sofia Silva Diaz
    Begoña Graña Suarez
    Juan de la Cámara Gomez
    Fernando Busto Fernández
    María Mateos Salvador
    Margarita Reboredo Lopez
    Scientific Reports, 12
12345